{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:21:43Z","timestamp":1781248903534,"version":"3.54.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["NARSAD Independent Investigator Award"],"award-info":[{"award-number":["NARSAD Independent Investigator Award"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA07255"],"award-info":[{"award-number":["T32 DA07255"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM07839"],"award-info":[{"award-number":["T32 GM07839"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211239","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T18:35:46Z","timestamp":1549391746000},"page":"e0211239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Dissecting the roles of \u03b2-arrestin2 and GSK-3 signaling in 5-HT1BR-mediated perseverative behavior and prepulse inhibition deficits in mice"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-1201","authenticated-orcid":true,"given":"Summer L.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Dulawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-6147(96)30002-3","article-title":"Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes","volume":"17","author":"PR Hartig","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000079970","article-title":"Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan","volume":"50","author":"R Gross-Isseroff","year":"2004","journal-title":"Neuropsychobiology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0924-977X(01)00082-7","article-title":"Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder","volume":"11","author":"LM Koran","year":"2001","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2016.02.021","article-title":"OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding","volume":"196","author":"C Pittenger","year":"2016","journal-title":"J Affect Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0278-5846(99)00051-2","article-title":"Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor","volume":"23","author":"DJ Stein","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00213-015-4086-8","article-title":"Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation","volume":"233","author":"EV Ho","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2011.07.032","article-title":"Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice","volume":"70","author":"NA Shanahan","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biopsych.2008.09.026","article-title":"Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice","volume":"65","author":"NA Shanahan","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00213-013-2985-0","article-title":"Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation","volume":"227","author":"NS Woehrle","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"ref10","first-page":"238","article-title":"Presidential Address, 1974. The more or less startling effects of weak prestimulation","volume":"12","author":"FK Graham","year":"1975","journal-title":"Psychophysiology"},{"key":"ref11","article-title":"Diagnostic and Statistical Manual of Mental Disorders: Dsm-5","year":"2013"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/npp.2011.308","article-title":"Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder","volume":"37","author":"SE Ahmari","year":"2012","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2005.09.025","article-title":"Sensorimotor Gating Deficits in Adults with Autism","volume":"61","author":"W Perry","year":"2007","journal-title":"Biol Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.1993.01820180039004","article-title":"A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder","volume":"50","author":"CT Gordon","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/14656566.2014.914493","article-title":"An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder","volume":"15","author":"M Pizarro","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.chc.2008.06.003","article-title":"Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders","volume":"17","author":"L Soorya","year":"2008","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0893-133X(99)00121-9","article-title":"The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder","volume":"22","author":"E Hollander","year":"2000","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02244547","article-title":"A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants","volume":"104","author":"MP Paulus","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpsyc.1990.01810180077011","article-title":"Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine","volume":"47","author":"WK Goodman","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1476-5381.1996.tb16705.x","article-title":"Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding","volume":"117","author":"H Giles","year":"1996","journal-title":"Br J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/sj.bjp.0704809","article-title":"Differential coupling of 5-HT(1) receptors to G proteins of the G(i) family","volume":"136","author":"SL Lin","year":"2002","journal-title":"Br J Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/mol.109.056994","article-title":"Regulation of serotonin 1B receptor by glycogen synthase kinase-3","volume":"76","author":"L Chen","year":"2009","journal-title":"Mol Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1124\/mol.111.071092","article-title":"Glycogen synthase kinase-3\u03b2 is a functional modulator of serotonin-1B receptors","volume":"79","author":"L Chen","year":"2011","journal-title":"Mol Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by beta-arrestins","volume":"308","author":"RJ Lefkowitz","year":"2005","journal-title":"Science"},{"key":"ref25","first-page":"1140","article-title":"Structure-based discovery of selective serotonin 5-HT(1B) receptor ligands","volume":"22","author":"D Rodr\u00edguez","year":"2014","journal-title":"Struct Lond Engl 1993"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FBP.0000000000000013","article-title":"Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG)","volume":"25","author":"PA Kantak","year":"2014","journal-title":"Behav Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1476-5381.1993.tb14010.x","article-title":"Evidence that RU 24969-induced locomotor activity in C57\/B1\/6 mice is specifically mediated by the 5-HT1B receptor","volume":"110","author":"SC Cheetham","year":"1993","journal-title":"Br J Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2012.03.027","article-title":"Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse","volume":"231","author":"NM Enman","year":"2012","journal-title":"Behav Brain Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8830","DOI":"10.1523\/JNEUROSCI.1292-10.2010","article-title":"Protein Phosphatase 2a and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-Type potassium channel activity","volume":"30","author":"D Kapfhamer","year":"2010","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainresbull.2010.03.005","article-title":"Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice","volume":"82","author":"JS Miller","year":"2010","journal-title":"Brain Res Bull"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S1461145710001495","article-title":"Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania","volume":"14","author":"M Kalinichev","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.pnpbp.2008.05.020","article-title":"Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice","volume":"32","author":"AO Rosa","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"R Bhat","year":"2003","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"MP Coghlan","year":"2000","journal-title":"Chem Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bjp.0707471","article-title":"Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation","volume":"152","author":"M-L Selenica","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"J-M Beaulieu","year":"2005","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","article-title":"A beta-arrestin 2 signaling complex mediates lithium action on behavior","volume":"132","author":"J-M Beaulieu","year":"2008","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1523\/JNEUROSCI.23-32-10265.2003","article-title":"Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice","volume":"23","author":"LM Bohn","year":"2003","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/syn.20625","article-title":"Nicotine sensitization and analysis of brain-derived neurotrophic factor in adolescent beta-arrestin-2 knockout mice","volume":"63","author":"JA Correll","year":"2009","journal-title":"Synap N Y N"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e43262","DOI":"10.1371\/journal.pone.0043262","article-title":"The effects of glycogen synthase kinase-3beta in serotonin neurons","volume":"7","author":"W Zhou","year":"2012","journal-title":"PloS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1538\/expanim.60.111","article-title":"Strain and sex differences in anxiety-like and social behaviors in C57BL\/6J and BALB\/cJ mice","volume":"60","author":"X-L An","year":"2011","journal-title":"Exp Anim"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2012.01.024","article-title":"Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine","volume":"136","author":"M-H Chan","year":"2012","journal-title":"Schizophr Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1601-183X.2004.00065.x","article-title":"Genetic correlational analysis of glycogen synthase kinase-3 beta and prepulse inhibition in inbred mice","volume":"3","author":"S Amar","year":"2004","journal-title":"Genes Brain Behav"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050333","article-title":"Inbred strain differences in prepulse inhibition of the mouse startle response","volume":"132","author":"R Paylor","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"EV Gurevich","year":"2012","journal-title":"Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-3057(00)00389-0","article-title":"Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists","volume":"67","author":"N Castanon","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ydbio.2009.12.042","article-title":"Loss of \u03b2arrestin1 and \u03b2arrestin2 contributes to pulmonary hypoplasia and neonatal lethality in mice","volume":"339","author":"M Zhang","year":"2010","journal-title":"Dev Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00125-013-3130-7","article-title":"\u03b2-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice","volume":"57","author":"MA Ravier","year":"2014","journal-title":"Diabetologia"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"LM Bohn","year":"1999","journal-title":"Science"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"E8178","DOI":"10.1073\/pnas.1614347113","article-title":"Distinct cortical and striatal actions of a \u03b2-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties","volume":"113","author":"NM Urs","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","first-page":"1139","article-title":"BREAKING THE CYCLE: ESTROUS VARIATION DOES NOT REQUIRE INCREASED SAMPLE SIZE IN THE STUDY OF FEMALE RATS","volume":"68","author":"A Dayton","year":"2016","journal-title":"Hypertens Dallas Tex 1979"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2014.01.001","article-title":"Female mice liberated for inclusion in neuroscience and biomedical research","volume":"40","author":"BJ Prendergast","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s002130050560","article-title":"Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test","volume":"136","author":"M Bourin","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0924-977X(00)00065-1","article-title":"Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial","volume":"10","author":"PN Dannon","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0028-3908(99)00192-6","article-title":"The role of 5-HT(1A) and 5-HT(1B\/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+\/-)pindolol","volume":"39","author":"LA Dawson","year":"2000","journal-title":"Neuropharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:51:49Z","timestamp":1588999909000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211239"}},"subtitle":[],"editor":[{"given":"Efthimios M. C.","family":"Skoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211239","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]}}}